Envista Holdings Co. (NYSE:NVST) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. boosted its holdings in Envista Holdings Co. (NYSE:NVST - Free Report) by 0.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,275,365 shares of the company's stock after purchasing an additional 29,714 shares during the quarter. Vanguard Group Inc. owned about 10.04% of Envista worth $333,242,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Franklin Resources Inc. boosted its position in shares of Envista by 26.5% in the 3rd quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company's stock valued at $78,480,000 after purchasing an additional 830,861 shares during the period. Geode Capital Management LLC grew its holdings in shares of Envista by 2.5% in the 3rd quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company's stock worth $57,233,000 after acquiring an additional 71,435 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Envista by 8.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,317,631 shares of the company's stock valued at $44,707,000 after acquiring an additional 179,600 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Envista during the third quarter worth $37,559,000. Finally, Paradice Investment Management LLC lifted its holdings in Envista by 3.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,652,332 shares of the company's stock valued at $31,873,000 after purchasing an additional 61,139 shares in the last quarter.

Envista Stock Down 3.7 %

NYSE NVST traded down $0.57 on Tuesday, hitting $14.73. 3,855,591 shares of the stock traded hands, compared to its average volume of 2,466,743. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The stock has a 50-day moving average of $18.78 and a 200 day moving average of $19.44. Envista Holdings Co. has a twelve month low of $14.47 and a twelve month high of $23.00. The company has a market capitalization of $2.54 billion, a P/E ratio of -2.27, a price-to-earnings-growth ratio of 1.27 and a beta of 1.12.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, analysts expect that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have commented on NVST shares. Morgan Stanley lowered their target price on shares of Envista from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Thursday, March 6th. Wells Fargo & Company set a $19.00 price target on Envista in a research report on Saturday, March 8th. New Street Research set a $19.00 target price on shares of Envista in a research note on Thursday, March 6th. Piper Sandler boosted their price target on Envista from $17.00 to $18.00 and gave the stock a "neutral" rating in a research report on Monday, February 3rd. Finally, Jefferies Financial Group increased their price objective on shares of Envista from $20.00 to $22.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $20.18.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.